Adverum (ADVM) Alert: Johnson Fistel Launches Investigation into Adverum Biotechnologies; Investors Encouraged to Contact Fir...

Date : 02/15/2020 @ 3:09PM
Source : PR Newswire (US)
Stock : Adverum Biotechnologies Inc (ADVM)
Quote : 8.95  0.0 (0.00%) @ 10:16PM
Adverum Biotechnologies share price Chart
After Hours
Last Trade
Last $ 8.95 ◊ 0.00 (0.00%)

Adverum (ADVM) Alert: Johnson Fistel Launches Investigation into Adverum Biotechnologies; Investors Encouraged to Contact Fir...

Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart

2 Months : From Feb 2020 to Apr 2020

Click Here for more Adverum Biotechnologies Charts.

SAN DIEGO, Feb. 15, 2020 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Adverum Biotechnologies, Inc. ("Adverum " or the "Company" (NASDAQ: ADVM) on behalf of investors. 

The investigation seeks to determine whether certain statements regarding the results of a clinical drug study of ADVM-022 were false and misleading when made.  ADVM-022 was intended to treat wet age-related macular degeneration ("wet AMD"). 

On September 12, 2019, Adverum issued a press release that disclosed that patients taking the drug in the study suffered significant deterioration in their sight.  Following this news, the price of Adverum's common stock dropped from $12.00 to $5.96 in one day, a decrease of more than 50%. 

If you lost money, realized or unrealized, on your Adverum investment, and are interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) by email or phone at 619-814-4471.  If emailing, please include a phone number.

Additionally, you can [click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com

[click here to join this action]

Cision View original content:http://www.prnewswire.com/news-releases/adverum-advm-alert-johnson-fistel-launches-investigation-into-adverum-biotechnologies-investors-encouraged-to-contact-firm-301005705.html

SOURCE Johnson Fistel, LLP

Copyright 2020 PR Newswire

Latest ADVM Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200404 17:48:38